Chemesis

Chemesis International Inc. enters into the cannabis edibles market

RSS
Facebook
Instagram

 

Chemesis International is making some headway recently including the announcement today in which they are entering into the cannabis edibles market.

Taken from the news release:

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) is pleased to announce it will be entering into the cannabis edibles category. Chemesis intends to use its existing facilities and licenses to streamline its entry into the expanding edibles market, providing services for businesses that need manufacturing, packaging, and distribution while maintaining compliance.
“Chemesis continues to enter into the most lucrative and important product categories,” said Edgar Montero, CEO of Chemesis. “Management is executing a strategic business plan that allows businesses to use Chemesis for all of their products and needs, making us a one stop shop. The recent regulation changes have put pressure on businesses to find compliant manufacturing and distribution; Chemesis continues to ensure it is a top choice for companies. Entering into the edibles category is another strategic move in our long-term business plan to ensure we build long term relationships that deliver a steady revenue stream.”
Read more

 

A fully compliant seed-to-sale company, specializing in extraction techniques for the medical marijuana market, operations are currently based in Puerto Rico and California.  Since the legalization of the medical marijuana market in Puerto Rico in May 2017, Chemesis has been an innovative leader selling cannabis products in approximately seven locations across the state.

 

With regards to offerings, Chemesis is presenting potential clients numerous forms of extractions, formulations and products, with a specialization in BHO Extraction, Alchohol Extraction, and CO2 Extraction with a current capability production of 2,000 pounds a day.

With the continual activities to grow the market stake in California, Chemesis ‘expected annual revenue in that state is projected to reach $61.5 million by year four with a net income of $27.2 million. The current medical marijuana market in California is estimated to be $3.7 billion in 2018 reaching $5.1 billion in 2019, leaving plenty of room for Chemesis to continue revenue growth.’  (Investment News Network: 2018 Article: Bringing Vertically-Integrated Cannabis to Puerto Rico and California).

Chemesis is one to watch and I look forward to continue to follow this interesting company.

Happy Investing!

Dr. Kal Kotecha

 

Disclaimer

© 2010 Junior Gold Report and TechMoney360

Junior Gold Report and TechMoney360 Newsletter: Junior Gold Report’s and Tech Money 360’s Newsletter is published as a copyright publication of Junior Gold Report (JGR) and TechMoney360 (TM360).  No Guarantee as to Content:  Although JGR/TM360 attempts to research thoroughly and present information based on sources we believe to be reliable, there are no guarantees as to the accuracy or completeness of the information contained herein. Any statements expressed are subject to change without notice. It may contain errors and you should not make any investment decisions based on what you have read on here. JGR/TM360, its associates, authors, and affiliates are not responsible for errors or omissions. By accessing the site and receiving this email, you accept and agree to be bound by and comply with the terms and conditions as set out herein. If you do not accept and agree to the terms you should not use the Junior Gold Report and TechMoney360 sites or accept this email. Consideration for Services: JGR/TM360, it’s editor, affiliates, associates, partners, family members, or contractors may have an interest or position in the featured companies, as well as sponsored companies which compensate JGR/TM360 as such our opinions are biased. We may hold potions in and trade these stocks of the companies we profile and as such our opinions are biased. JGR/TM360 and its’ owner and affiliates/associates may buy/sell and trade the featured companies from time to time. JGR/TM360 has been paid by the companies. JGR have been paid 100,000 options by Chemesis. Thus, multiple conflicts of interest exist.  Therefore, information provided here within should not be construed as a financial analysis but rather as an advertisement. Conduct your own due diligence: The author’s views and opinions regarding the companies featured in report(s) are his/her own views and are based on information that he/she has researched independently and has received, which the author assumes to be reliable. You should never base any buying/selling/trading decisions off of our emails, newsletter, website, videos or any of our published materials. JGR/TM360 aims to provide information and often stock ideas but are by no means recommendations. The ideas and companies featured are highly speculative and you could lose your entire investment – consult a licensed financial advisor if you are considering investing in any of the featured companies. Subscribers/readers are encouraged to conduct their own research and due diligence. The companies mentioned are high risk and considered penny stocks that contain a high risk of volatility, therefore consult your investment advisor and do your own due diligence before purchasing. Never base any investment decision on information contained from our emails, newsletter, website, videos or any of our published materials. No Offer to Sell Securities: JGR/TM360 is not a registered broker dealer, investment advisor, financial analyst, stock picker, investment banker or other investment professional. JGR/TM360 is intended for informational, educational and research purposes only. It is not to be considered as investment advice. No statement or expression of any opinions contained in this report constitutes an offer to buy or sell the shares of the companies mentioned herein. Links: JGR/TM360 may contain links to related websites for stock quotes, charts, etc. JGR/TM360 is not responsible for the content of or the privacy practices of these sites. Information contained herein was extracted from public filings, profiled company websites, and other publicly available sources deemed reliable. Information in this report was taken on or before writing and dissemination and may not be updated. Do you own due diligence as information and events can and do change. Published reports may reference company websites or link to company websites and we disclaim and responsibility for the content and accuracy of any such information or website. Release of Liability: By reading and/or watching videos by JGR/TM360, you agree to hold JGR/TM360, its associates, sponsors, affiliates, and partners harmless and to completely release them from any and all liabilities due to any and all losses, damages, or injuries (financial or otherwise) that may be incurred.

 

Forward Looking Statements
Except for statements of historical fact, certain information contained herein constitutes forward-looking statements. Forward looking statements are usually identified by the use of certain terminology, including “will”, “believes”, “may”, “expects”, “should”, “seeks”, “anticipates”, “has potential to”, or “intends’ or by discussions of strategy, forward looking numbers or intentions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results or achievements to be materially different from any future results or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts, and include but are not limited to, estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to the effectiveness of the Company’s business model; future operations, products and services; the impact of regulatory initiatives on the Company’s operations; the size of and opportunities related to the market for the Company’s products; general industry and macroeconomic growth rates; expectations related to possible joint and/or strategic ventures and statements regarding future performance. Junior Gold Report/TechMoney360 does not take responsibility for the accuracy of forward looking statements and advises the reader to perform their own due diligence on forward looking numbers or statements.

 

Want the Best News?
Increase your wealth by staying informed:
Trend Alerts - Exclusive Articles - Videos
We respect your privacy.
RSS
Facebook
Instagram